You have read all your free articles, to continue reading subscribe to read the rest of this content.
Meda has signed an agreement to divest the manufacturing unit in Lakewood, New Jersey. The manufacturing unit will be divested to the contract manufacturer DPT. According to Meda the manufacturing facility is dedicated to global supply of the product MUSE. As part of the agreement Meda has enAlready a subscriber Login…
The round was led by Debiopharm Innovation Fund in conjunction with Tesi, a Finnish venture capital and private equity company, and was supported by BC Platforms’ existing investors. To date, the company has established partnerships with over 50 enterprise level healthcare units and biobanks gAlready a subscriber Login You have read…
Pelago Bioscience AB and AstraZeneca have entered into a 2-year strategic research collaboration and license agreement. The companies will collaborate on specified joint projects and AstraZeneca will also be granted a license to use and apply the Cellular Thermal Shift Assay (CETSA®) for determAlready a subscriber Login You have read all…
Immedica Pharma and Japanese company OrphanPacific entered an agreement under which OrphanPacific gains the exclusive rights to Ravicti in Japan. The pharmaceutical drug product Ravicti is approved in Europe and North America for treatment of urea cycle disorders (UCD). Under the announced parAlready a subscriber Login You have read all…
